NASDAQ
Kane Biotech Inc. (KNBIF) has a free cash flow growth of 17.20% as of Friday, May 29, 2026. This represents a 175.93% increase compared to its 12-month average of -22.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.